Financial results - ANAMED NEFRO SRL

Financial Summary - Anamed Nefro Srl
Unique identification code: 37300155
Registration number: J40/4283/2017
Nace: 8622
Sales - Ron
5.538
Net Profit - Ron
-236
Employees
Open Account
Company Anamed Nefro Srl with Fiscal Code 37300155 recorded a turnover of 2024 of 5.538, with a net profit of -236 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Anamed Nefro Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 2.665 18.078 3.916 2.494 5.407 3.944 5.483 5.538
Total Income - EUR - - 2.699 18.079 3.918 2.494 5.482 3.944 5.486 5.697
Total Expenses - EUR - - 6.391 8.903 4.788 662 698 1.528 4.750 5.664
Gross Profit/Loss - EUR - - -3.693 9.176 -870 1.832 4.784 2.417 735 34
Net Profit/Loss - EUR - - -3.773 8.634 -987 1.761 4.623 2.316 397 -236
Employees - - 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 1.6%, from 5.483 euro in the year 2023, to 5.538 euro in 2024. The Net Profit decreased by -395 euro, from 397 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Anamed Nefro Srl

Rating financiar

Financial Rating -
ANAMED NEFRO SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Anamed Nefro Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Anamed Nefro Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Anamed Nefro Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Anamed Nefro Srl - CUI 37300155

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 0 0 0 0 0 0 0 525
Current Assets - - 3.280 5.641 5.179 2.796 4.991 3.165 621 575
Inventories - - 0 0 0 0 0 0 0 1
Receivables - - 0 0 446 106 452 104 525 33
Cash - - 3.280 5.641 4.733 2.690 4.539 3.060 95 541
Shareholders Funds - - -3.729 4.973 -937 842 4.671 3.149 446 207
Social Capital - - 44 43 42 41 40 41 40 40
Debts - - 7.171 667 6.116 1.954 320 15 175 893
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 575 euro in 2024 which includes Inventories of 1 euro, Receivables of 33 euro and cash availability of 541 euro.
The company's Equity was valued at 207 euro, while total Liabilities amounted to 893 euro. Equity decreased by -236 euro, from 446 euro in 2023, to 207 in 2024.

Risk Reports Prices

Reviews - Anamed Nefro Srl

Comments - Anamed Nefro Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.